We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPB icon
1176
Turning Point Brands
TPB
$1.52B
$6.37M 0.01%
187,391
+33,779
+22% +$1.15M
YEXT icon
1177
Yext
YEXT
$554M
$6.37M 0.01%
923,933
+852,937
+1,201% +$6.51M
ZT
1178
DELISTED
Zimmer Energy Transition Acquisition Corp. Class A Common Stock
ZT
$6.36M 0.01%
654,060
TSPQ.WS
1179
CALL
DELISTED
TCW Special Purpose Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TSPQ.WS
$6.35M 0.01%
651,181
GM icon
1180
General Motors
GM
$78.7B
$6.34M 0.01%
144,996
-158,935
-52% -$7.94M
FCX icon
1181
Freeport-McMoran
FCX
$90.2B
$6.34M 0.01%
127,455
+53,158
+72% +$2.35M
SIRI icon
1182
SiriusXM
SIRI
$10.5B
$6.33M 0.01%
+95,540
New +$6.01M
POW
1183
DELISTED
Powered Brands Class A Ordinary Shares
POW
$6.32M 0.01%
642,504
CERO
1184
DELISTED
CERo Therapeutics
CERO
$6.29M 0.01%
314
SANB
1185
DELISTED
Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
$6.29M 0.01%
628,774
MRNA icon
1186
PUT
Moderna
MRNA
$22.1B
$6.29M 0.01%
36,500
+34,000
+1,360% +$5.72M
BKE icon
1187
Buckle
BKE
$2.25B
$6.29M 0.01%
190,346
+47,350
+33% +$1.75M
COST icon
1188
PUT
Costco
COST
$422B
$6.28M 0.01%
10,900
-4,800
-31% -$2.52M
BRCC.WS
1189
CALL
DELISTED
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
$6.26M 0.01%
+300,000
New +$953K
BSKY
1190
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
$6.24M 0.01%
641,928
NPWR icon
1191
NET Power
NPWR
$128M
$6.23M 0.01%
632,014
+351,900
+126% +$3.47M
PSAG
1192
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
$6.22M 0.01%
636,635
+262,143
+70% +$2.55M
MBAC.WS
1193
CALL
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$6.22M 0.01%
636,666
+7,055
+1% +$4.26K
SFR
1194
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
$6.2M 0.01%
630,779
+241,400
+62% +$2.36M
PTR
1195
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$6.2M 0.01%
122,694
-83,664
-41% -$4.25M
KRP icon
1196
Kimbell Royalty Partners
KRP
$1.45B
$6.19M 0.01%
381,034
-276,850
-42% -$4.3M
LILAK icon
1197
Liberty Latin America Class C
LILAK
$1.55B
$6.19M 0.01%
710,285
+303,875
+75% +$2.89M
AAQC.WS
1198
CALL
DELISTED
Accelerate Acquisition Corp Warrants
AAQC.WS
$6.18M 0.01%
633,328
VELO
1199
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
$6.16M 0.01%
631,826
+9,283
+1% +$90.3K
SHCA
1200
DELISTED
Spindletop Health Acquisition Corp. Class A Common Stock
SHCA
$6.16M 0.01%
612,833
+262,833
+75% +$2.61M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.